Replies to post #327471 on Avid Bioservices Inc (CDMO)

[north40000]

Why do you ignore the recent UTSW/Merck collaboration with Bavi and Keytruda in a new clinical trial? One or both spending excess $$$ just for fun?

Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
Merck Sharp & Dohme Corp.

https://www.clinicaltrials.gov/ct2/show/NCT03519997?term=Pembrolizumab%2C+Bavituximab&rank=1

[Threes]

Not so fast with the death of the dream. Bavi and PS may be in capable hands that knew what they were getting into. They may have the right people and we have IMO a solid deal. Already beyond a DIOS or Stanton type deal. They actually paid 6 million in cash and are about to pony up anther 2. All the while buying Bavi for the trials and paying retail according to the last CC.

So while I do not focus on PS and I value CDMO only when investing at this point.
I do not dismiss the fact that we may hit a home run and the SP will surprise us.
So under promise and hope for the best while we make hay with the CDMO side of the business.